O'Shaughnessy Asset Management, LLC Novavax Inc Transaction History

O'Shaughnessy Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $90,424 - $146,475	-672 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $5,689 - $8,658	32 Added 5.0%	672 $140,000
Q2 2021 Aug 09, 2021	SELL	$121.0 - $257.67 $15,004 - $31,951	-124 Reduced 16.23%	640 $136,000
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $9,829 - $27,833	87 Added 12.85%	764 $138,000
Q4 2020 Feb 11, 2021	SELL	$78.74 - $139.5 $112,598 - $199,485	-1,430 Reduced 67.87%	677 $75,000
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $167,380 - $376,120	2,107 New	2,107 $229,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.